| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requester: Very Good Fit; While this fungicide has one of its premix actives in the same FRAC group as Quadris it offers a novel FRAC code that could assist in delaying/preventing pathogen resistance. Could be used in conjunction with the disease forecaster TOMCAST.
|
| Reasons for need: |
Stemphylium vesicarium (purple spot) on the fern. Responsible for premature defoliation and subsequent yield loss. Heavy fern infection results in the pathogen overwintering and causing spear blemishes that result in crop rejection.Lack of registered products. Mancozeb, chlorothalonil, and Quadris are currently registered. Miravis Prime is in the IR-4 pipline:07/24;
|
| Requesting State(s): |
MI:Hausbeck, M* ;
|
| PCR Use Pattern: |
Use Tanos 8 oz/A; Up to 3 foliar applications @ 7-10 day interval; PHI= 120 days
|
| EPA Default Residue Trials: |
2 5-2 10-3 11-2
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
for application to the fern once it expands following the conclusion of the spear harvest:07/24/sb
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|